TP53 and FLG genes were more frequently mutated in metastases than in primary tumors (66% versus 33% ( P = 0.006) and 28% versus 3% ( P = 0.003), respectively); however, this finding did not reach statistical significance after false discovery rate (FDR) adjustment.
← all excerpts
Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.
1
—
—